FDA Inspection 712093 — DAVA Pharmaceuticals, Inc.

DAVA Pharmaceuticals, Inc. — FEI 3006193930

The FDA completed an inspection of DAVA Pharmaceuticals, Inc. on Mar 3, 2011 in Fort Lee, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 3, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Lee, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.